Tag Archives: Yaron Werber

BeiGene Ltd (BGNE) Receives a Buy from Cowen & Co.

Cowen & Co. analyst Yaron Werber maintained a Buy rating on BeiGene Ltd (BGNE – Research Report) today and set a price target of $170.00. The company’s shares closed last Monday at $126.52. According to TipRanks.com, Werber is a 4-star

Analysts’ Top Healthcare Picks: Acceleron Pharma (XLRN), Incyte Corp (INCY)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acceleron Pharma (XLRN – Research Report) and Incyte Corp (INCY – Research Report) with bullish sentiments. Acceleron Pharma (XLRN) Cowen & Co.

Orchard Therapeutics PLC (ORTX) Initiated with a Buy at Cowen & Co.

In a report issued on September 13, Yaron Werber from Cowen & Co. initiated coverage with a Buy rating on Orchard Therapeutics PLC (ORTX – Research Report) and a price target of $27. The company’s shares closed last Monday at

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE), Matinas BioPharma (NYSE MKT: MTNB) and ESSA Pharma Inc (NASDAQ: EPIX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ultragenyx Pharmaceutical, Inc. (RARE – Research Report), Matinas BioPharma (MTNB – Research Report) and ESSA Pharma Inc (EPIX – Research Report) with

Stoke Therapeutics Inc (STOK) Receives a Buy from Cowen & Co.

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Stoke Therapeutics Inc (STOK – Research Report) yesterday. The company’s shares closed last Monday at $30.27, close to its 52-week high of $31.76. According to TipRanks.com, Werber is a

Cowen & Co. Keeps Their Buy Rating on BeiGene Ltd (BGNE)

In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on BeiGene Ltd (BGNE – Research Report), with a price target of $170. The company’s shares closed yesterday at $133.48. According to TipRanks.com, Werber is